Q-omics provides the consensus-scored PRAMEF36P profile across patient tissues and cancer cell-line models. PRAMEF36P expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in COAD. Additionally, PRAMEF36P RNA expression shows 546 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight COAD, and ESCA as cancer lineages where PRAMEF36P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.